[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338308-105":59,"doc-detail-338308-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","application-of-h2n-fe3o4-nanoparticles-for-prostate-cancer-magnetic-resonance-imaging-in-an-animal-model","Application of H2N-Fe3O4 Nanoparticles for Prostate Cancer Magnetic Resonance Imaging in an Animal Model","","This paper presents the efficacy of a contrast agent based on H2N-Fe3O4 nanoparticles for detecting prostate cancer in an animal model using a preclinical 9.4 T MRI system. Relaxivities r1 and r2 of the nanoparticles were 6.31 mM−1s−1 and 8.33 mM−1s−1, respectively. After injection at 2 mg Fe/mL, tumor-relative T1 relaxation decreased across multiple post-injection time points, while tumor-relative T2 changes also shifted. Differences in relative T1 and T2 were statistically significant only at 12 min (p\u003C0.05), indicating time-dependent contrast behavior and potential suitability of the agent for enhanced prostate cancer MRI.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/application-of-h2n-fe3o4-nanoparticles-for-prostate-cancer-magnetic-resonance-imaging-in-an-animal-model/338308/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/application-of-h2n-fe3o4-nanoparticles-for-prostate-cancer-magnetic-resonance-imaging-in-an-animal-model/338308.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What contrast agent is evaluated for prostate cancer MRI in this study?","Question",{"text":112,"@type":113},"The study evaluates H2N-Fe3O4 nanoparticles as a contrast agent for prostate cancer detection.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which MRI system and relaxivity parameters were used to assess the nanoparticles?",{"text":117,"@type":113},"Experiments use a preclinical 9.4 T MRI system, and the nanoparticles’ r1 and r2 relaxivities are reported as 6.31 mM−1s−1 and 8.33 mM−1s−1, respectively.",{"name":119,"@type":110,"acceptedAnswer":120},"How did the nanoparticles affect tumor relaxation times over time?",{"text":121,"@type":113},"After injection (2 mg Fe/mL), tumor-relative T1 decreased across all animals at multiple post-injection time points, and tumor-relative T2 showed corresponding changes. Significant differences between groups were observed only at 12 minutes (p\u003C0.05).","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338308,1790194372,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Communication  \nApplication of H 2N-Fe3 O4 Nanoparticles for Prostate Cancer Magnetic Resonance Imaging in an Animal Model  \nBarbara Blasiak 1, *, David MacDonald 1, Krzysztof Jasi ´nski 1, Fong-Yu Cheng 2 and Boguslaw Tomanek 1,3  \nCitation: Blasiak, B.; MacDonald, D.; Jasi ´nski, K.; Cheng, F.-Y.; Tomanek, B. Application of H2N-Fe3O4  \nNanoparticles for Prostate Cancer Magnetic Resonance Imaging in an Animal Model. Int. J. Mol. Sci. 2024, 25, 10334. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms251910334  \nAcademic Editor: Nam Deuk Kim  \nReceived: 22 August 2024  \nRevised: 23 September 2024  \nAccepted: 24 September 2024  \nPublished: 26 September 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 The Henryk Niewodniczanski Institute of Nuclear Physics Polish Academy of Sciences, Radzikowskiego 152, 31-342 Krakow, Poland; [david.macdonald@ifj.edu.pl](david.macdonald@ifj.edu.pl) (D.M.); [krzysztof.jasinski@ifj.edu.pl](krzysztof.jasinski@ifj.edu.pl) (K.J.); [tomanek@ualberta.ca](tomanek@ualberta.ca) (B.T.)  \n2 Department of Chemistry, Chinese Culture University, Taipei 11114, Taiwan; [zfy3@ulive.pccu.edu.tw](zfy3@ulive.pccu.edu.tw)  \n[3](3 Division of Medical Physics)[ Division of Medical Physics](3 Division of Medical Physics), [Department of Oncology](Department of Oncology), [University of Alberta](University of Alberta), [8303 112 St](8303 112 St). NW, Edmonton, AB T6G 2T4, Canada  \n* [Correspondence: barbara.blasiak@ifj.edu.pl](Correspondence: barbara.blasiak@ifj.edu.pl)  \nAbstract: This paper presents the efficacy of a contrast agent based on H 2N-Fe3O4 nanoparticles for the detection of prostate cancer in an animal model using a preclinical 9.4 T MRI system. Therelaxivities r1 and r2 of the nanoparticles were 6 .31 mM−1s−1 and 8 .33 mM−1s−1, respectively. Nanoparticles injected in a concentration of 2 mg Fe/mL decreased the tumor-relative T1 relaxation across all animals from 100 to 76 ± 26, 85 ± 27, 89 ± 20, and 97 ± 16 12 min 1 h, 2 h, and 24 h post injection, respectively. The corresponding T 1 decrease in muscle tissues was 90 ± 20, 94 ± 23, 99 ± 12, and 99 ± 14. The relative T2 changes in the tumor were 82 ± 17, 89 ± 19, 97 ± 14, and 99 ± 8 12 min, 1 h, 2 h, and 24 h post injection, respectively, while, for muscle tissues, these values were 95 ± 11, 95 ± 8, 97 ± 6, and 95 ± 10 at the corresponding time points. The differences in the relative T1 and T2 were only significant 12 min after injection (p \u003C 0.05), although a decrease was visible at each time point, but it was statistically insignificant (p > 0.05) . The results showed the potential application of H2N-Fe3O4 nanoparticles as contrast agents for enhanced prostate cancer MRI.  \nKeywords: magnetic resonance imaging (MRI); contrast agents; nanoparticles; prostate cancer; mouse animal model; iron oxide nanoparticles  \n1. Introduction;  \nProstate cancer (PC) is a curable disease if diagnosed early; however, if undetected, it can spread aggressively and has few early symptoms, leading to late diagnosis and, hence, problematic outcomes [1] . Therefore, early diagnosis and timely efficient treatment are essential for effective cancer management. Currently, the established standard for PC diagnosis involves prostate-specific antigen testing and digital rectal examination [2] . However, these diagnostic methods often lead to overdiagnosis and overtreatment [3], given that only a small percentage of these cancers metastasize, and approximately 3% of them result in fatalities [3–7] . While transrectal ultrasonography, computed tomography (CT), positron emission tomography (PET) [8], and magnetic resonance imaging (MRI) [9","cbCaidsCchhr9J5G","https://ap.wps.com/l/cbCaidsCchhr9J5G","pdf",2641611,"English","# Abstract\n# Introduction","[{\"question\":\"What contrast agent is evaluated for prostate cancer MRI in this study?\",\"answer\":\"The study evaluates H2N-Fe3O4 nanoparticles as a contrast agent for prostate cancer detection.\"},{\"question\":\"Which MRI system and relaxivity parameters were used to assess the nanoparticles?\",\"answer\":\"Experiments use a preclinical 9.4 T MRI system, and the nanoparticles’ r1 and r2 relaxivities are reported as 6.31 mM−1s−1 and 8.33 mM−1s−1, respectively.\"},{\"question\":\"How did the nanoparticles affect tumor relaxation times over time?\",\"answer\":\"After injection (2 mg Fe/mL), tumor-relative T1 decreased across all animals at multiple post-injection time points, and tumor-relative T2 showed corresponding changes. Significant differences between groups were observed only at 12 minutes (p\\u003c0.05).\"}]","Application of H2N-Fe3O4 Nanoparticles for Prostate Cancer Magnetic Resonance Imaging in an Animal Model | PDF",1790022992,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec9834b76bd4380a6d787e0c6e4f5e2b.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf9ae675bdb3e0973b1fd59e4dd0a69a.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2fc3347de33df6e65b0a3cf421b24f7a.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7382f8ff35cfa7eec562ac0d99f87751.webp",980,1385]